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In a  preceding communication (1) it has been shown that during an attack 
of mumps or convalescence therefrom specific antibody appears in the patient's 
serum which has the capacity to fix complement in the presence of an antigen 
derived from the parotid gland of a  monkey previously inoculated with  the 
virus.  The antibodyin nearly all individuals became demonstrable by the 14th 
day  following the  onset.  From  these  observations  it  became  immediately 
apparent that the complement fixation test might be of value in the differential 
diagnosis of the clinical syndrome which has been designated "acute aseptic 
meningitis," "infectious encephalitis," or "acute aseptic meningoencephalitis" 
(2,  3). 
In addition to that of mumps, a variety of viruses and possibly other agents 
whose nature is entirely unknown may give rise to this condition.  Among the 
known viruses  are  those  of mumps,  lymphocytic choriomeningitis,  Western 
equine encephalomyelitis, St. Louis encephalitis, Japanese encephalitis, Russian 
encephalitis, the virus of louping ill which is probably identical with that of 
Russian  encephalitis,  and  poliomyelitis.  Diagnosis  in  the  laboratory--the 
only means of etiologic determination--is in the case of certain of these patho- 
gens often a  difficult and prolonged procedure; and for the recognition of the 
virus of mumps as a neurotrope, there is of course no practical method avail- 
able.  Even when careful studies have been made, the diagnosis in the majority 
has remained obscurO. 
In the present communication are described the results obtained by means 
of the complement fixation test for mumps antibody in 51 patients who exhib- 
ited symptoms which clinically were compatible with the diagnosis of acute 
aseptic meningoencephalitis.  The analysis of the data which follows indicates 
that the technique should be of aid in the determination of those cases of this 
disease which are due to the virus of mumps. 
* These investigations have been carried out as a project of the Commission on Measles 
and Mumps, Board for the Investigation of Influenza and Other Epidemic Diseases, Pre- 
ventive Medicine Service, Office  of the Surgeon General, United States Army. 
For a recent review of this subject, see reference 4. 
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Procedure 
Specimens of serum, and when practicable, samples of spinal fluid were obtained as oc- 
casion offered during the last 2½ years from patients who presented the symptoms of acute 
aseptic  menlngoencephalitis.  Most  of  them  were hospitalized in civilian  institutions in 
Boston and elsewhere; a few cases occurred in base hospitals at Army camps in the United 
States and the remainder were house patients in Boston.  ~  Whenever possible such materials 
were procured during the  earlier stages of the illness and again during convalescence.  In 
certain instances specimens were secured only during the later period of the disease or after 
recovery.  Both  serum and spinal fluid were tested  for the presence of complement-fixing 
antibody according to the technique which is fully described in the first paper of this series 
(5).  Unheated spinal fluid from 7 patients was tested for the presence of antigen by substi- 
tuting it for the suspension of infected monkey parotid in titrations in which known positive 
mumps sera were employed.  All specimens were found by inoculation  into suitable media 
to be free of bacteria.  Hinton tests on the sera and Wassermann tests on the spinal  fluids 
of the 47 hospitalized patients were shown to  be negative.  In most of the  hospitalized 
group, both total and differential leucocyte counts on the blood and spinal fluid were also 
carried out, and the protein and sugar contents of the spinal fluid were determined.  Addi- 
tional pertinent clinical data were derived from the hospital records. 
Thirty-four  of these individuals who have been studied at no time during their illness 
revealed any indication of involvement of the salivary glands.  In the remaining 17 patients 
either parotitis or enlargement of the submaxillary or sublingual glands pointed to the nature 
of the etiologic agent.  In 5 of these cases orchitis was likewise  present. 
RESULTS 
The results of  the  complement fixation tests  together with the history of 
exposure and other relevant information are  given in Tables I, II,  and III. 
The records of the 17 individuals in which enlargement of the salivary glands 
was noted are presented as a group in Table I.  The pertinent findings recorded 
in the study of the remaining 34 patients are arranged according to the titers 
of  the  complement fixation test.  In  Table  II  are  summarized  the  results 
obtained in those patients that either exhibited an increase in antibody asso- 
ciated chronologically  with their illness or possessed a concentration of antibody 
sufficiently high as to suggest a  recent infection with the virus of mumps.  In 
contrast, the individuals mentioned in Table III were characterized either by 
the  absence of  antibody or  its  presence  in low  and  essentially unchanging 
amount. 
2 We wish to express our thanks to the following  individuals for their indispensable interest 
and assistance in obtaining the materiais employed in this investigation: Dr. Conrad Wessel- 
hoeft and Dr.  Charles Oliver of the Haynes  Memorial Hospital,  Boston; Dr.  Charles A. 
Janeway of the Children's Hospital, Boston; Dr. Allan Butler of the Massachusetts General 
Hospital; Dr. T. Hale Ham of the Boston City Hospital; Dr. Francis G. Blake of the New 
Haven Hospital; Dr. Joseph Stokes, Jr., of the Children's Hospital, Philadelphia, and Captain 
Carl T. Nelson of the United States Army.  To Dr. Janeway and Mrs. M. B. Meyer, work- 
ing in his laboratory, we are indebted for the permission to mention the data they obtained 
in the study of a number  of cases of suspected lymphocytic choriomeningitis.  We are grateful 
to Mrs. Jcanette  H. Levens and Miss Beatrice Payson for essential technical assistance. LEWIS W. KANE AND JOIIN F. ENDERS  139 
Table IV includes the percentage incidence of the most salient clinical fea- 
tures observed in the 3 groups.  The results of total and differential leucocyte 
counts of the  blood and  spinal fluid are recorded in Table V.  The range of 
protein concentration of the spinal fluid of the majority of the individuals in 
each group was as follows :- 
Group  No. persons tested  Protein 
mg./ml. 
1  13  26-67 
2  11  25-74 
3  18  11-132 
The quantities of sugar present in these same specimens of spinal fluid were 
found to be within the normal limits.  The distribution  of the cases accord- 
ing to the months in which they occurred is noted in Table VI. 
DISCUSSION 
Before attempting to analyze these data, it is essential to discuss the eval- 
uation  of the  results  which may be  obtained by means  of file complement 
fixation test.  The investigations in monkeys and in patients with mumps have 
shown  that  infection with  the  virus  is  regularly followed, usually  within  a 
comparatively short time, by the emergence or increase of specific complement- 
fixing antibody  (1,  5).  Therefore, when either of these phenomena can be 
demonstrated in cases of encephalitis they appear to afford as definite evidence 
for the presence of mumps infection as could be secured by any method other 
than the direct demonstration of the virus. 
Since meningoencephalitis, however, is frequently a  late complication of a 
mumps infection which may be apparent or inapparent  (1, 6)  and since the 
antibody may often reach high levels within the early stages of such infection 
when involvement of the nervous system is not yet manifest, it may often be 
impossible, as will be seen, to demonstrate either the emergence or increase of 
antibody.  Accordingly under  such  circumstances  it  becomes necessary,  in 
order to derive any diagnostic assistance from the test, to attempt the defini- 
tion of that level of antibody which may be considered indicative of a  recent 
infection with the virus. 
The results presented in the preceding paper  (1)  show that of 31  mumps 
patients whose sera were studied during both the acute and early convalescent 
stages, 20 exhibited titers of 1:96 or greater within the period from the 7th to 
the 13th day inclusive after the onset.  Of the remainder, 3 were negative, 2 
had titers of 1:24, 2 of 1:48, and 4 of 1:96.  Of 27 patients whose convalescent 
sera were tested during the later period of convalescence, i.e.  from the 14th to 
the 30th day inclusive, 26 were characterized by titers greater than 1:96 and 
only 1 had a titer of 1:48.  Thus apparently in typical cases of mumps about 
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the 1st week of illness and by the end of the 2nd week over nine-tenths will have 
titers in excess of that figure. 
In a  statistical study (6) of the titer of complement-fixing antibody in the 
sera of healthy individuals who gave no recent history of mumps it was found 
that among 198 whose sera yielded positive tests, only 12 had titers that were 
greater than 1:48.  Of these highest titers 11 were recorded as 1:96 and 1 only 
as 1 : 192.  We may, then, expect to encounter very rarely in a normal person a 
titer comparable to those almost uniformly characteristic of individuals who 
have recently recovered.  A titer of 1 : 192 may therefore be regarded with only 
a small chance for error as evidence of a recent infection, even when no rise in 
antibody  concentration  can  be  subsequently  demonstrated.  It  cannot  be 
assumed, however, that the recent infection so indicated is necessarily associ- 
ated causally with  the encephalitis,  since it has been demonstrated (1) that 
antibody may persist in  the  convalescent (and presumably in him who has 
has  experienced an  inapparent  infection)  at  high  levels for several months 
after the attack.  Although unlikely, a high titer may thus be an indication of 
an  infection with  the  virus  of mumps  experienced within  the  immediately 
preceding months, and so quite unrelated to the disease of the nervous system 
under investigation. 
In summary, we believe the results of the complement fixation test when 
employed in  the  diagnosis  of meningoencephalitis may,  in  the  light  of our 
present knowledge, be interpreted in the following manner.  If the develop- 
ment or increase of antibody can be demonstrated during the disease or shortly 
after  recovery, presumably  the  symptoms  are  related  to  the  concomitant 
infection by the virus of mumps which has  thus been revealed.  When the 
increase of antibody is the criterion, such increase must be at least 4 times that 
of the concentration initially determined to attain definite significance.  If no 
development or significant increase in antibody is demonstrated but a  titer of 
1:192 or over is obtained, it may be inferred that  a  recent infection (either 
apparent or inapparent) has occurred which probably, although not necessarily, 
is responsible for the observed disorder. 
Turning now to a  consideration of the results of the complement fixation 
tests in the cases of meningoencephalitis, it is clear that with 1 exception those 
patients  in  whom  involvement of the  salivary glands  was  noted  (Table I) 
presented titers of 1:192 or greater at periods varying from 8 to 50 days after 
the first symptoms of encephalitis were observed.  In 10 of these 17  patients, 
development or significant increases of antibody occurred.  In addition  the 
serum of patient 8 showed an increase of threefold which is suggestive.  Among 
the remaining 6 individuals only a single specimen of serum was obtained, and 
from 3 of them relatively late in the course of the illness.  The titers of these 3 
specimens, however, were all 1:192 or greater.  No increase was demonstrated 
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from each 2 specimens of serum were secured.  In 1 of them (No. 6)  the first 
specimen was drawn as early as the 1st day, and the 2nd on the 8th day after 
the onset of the encephalitis.  The titers were both found to be 1:384.  This 
indicates  that  considerable  antibody  may  be  produced  by  the  pre-existing 
infection of the salivary glands before symptoms of involvement of the nervous 
system are apparent. 
Although all the cases in group 1 exhibited involvement of the glands, it will 
be seen from the notes in the table that the swelling was minimal in several and 
involved only the submaxillary or sublingual glands.  Such trifling enlargement 
might easily have been overlooked or have subsided unless repeated examina- 
tions had been made.  If these slight manifestations had  gone unremarked, 
the evidence afforded by the complement fixation test would have been of great 
diagnostic value especially in those instances where no history of exposure could 
be given. 
Taken as a  whole,  the study of patients  in group  1,  in whom  the  clinical 
diagnosis was definite, illustrates the behavior of the complement fixation test 
in mumps meningoencephalitis.  The data afford a  sort of standard by which 
the results of the test may be judged in those cases in which only involvement 
of the nervous system was evident.  With the exception of 2 individuals exhibit- 
ing  some  involvement of  the  testes,  they are patients  of this  sort who are 
mentioned in Tables II and III.  The grouping, as previously stated, has been 
made on the basis of the titers of complement-fixing antibody. 
All the individuals included in group 2 (Table II) either showed an  increase 
in  antibody or a  significant  concentration  at  the  time  the first specimen of 
serum  was  obtained.  A  comparison of  their  titers  with  those  obtained  for 
group  1 in general reveals a  close parallelism in the values.  In a  few cases, 
those  with  salivary  gland  involvement  attained  somewhat  higher  levels  of 
antibody,  but  there  is no  indication  that  they should be regarded otherwise 
than as examples of individual variation.  The number of cases in which it was 
possible to demonstrate a significant rise in titer coincident with the illness was 
only one-half that of group 1.  In several of these instances a second specimen 
of serum was not obtained which, had it been available, might possibly have 
shown an increase in antibody.  Again as compared with group 1, there were 
also in group 2 fewer individuals who gave no history of exposure to mumps. 
Such  differences, however, are almost certainly due  to chance variation.  It 
is, therefore, reasonable to infer on the basis of the similarity of serologic find- 
ings to those encountered in group 1 that the patients in whom no glandular 
involvement was discerned likewise had been infected with the virus of mumps 
which in turn was responsible for the symptoms of meningoencephalitis. 
The results of the complement fixation tests on the sera of the  18 patients 
mentioned in Table III are obviously in marked contrast to those of groups 1 
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TABLE  I 
Group 1---Ca~es of Meningoencephalitis with Involvement of the Salivary Glands Showing 
Significant Titers of Complement-Fixing Antibody 
Ca~  Age 
No. 
ysars 
1  24  F 
2  19  M 
3  47~  F 
4  17  M 
5  28  M 
6  7  F 
7  9~  F 
8  12  M 
9  36  M 
10  16  M 
11  25  M 
12  26  F 
Comple-  Ist serum  Comple-  2nd serum  Known 
ment-  taken  ment-  taken  expos- 
Sex  fixing  (thne after  fixing  (time after  ure  (time  titer 1st  onset en-  titer 2rid  onset en-  before 
serum*  cephalitis)  serum  cephalitis) onset:~) 
> 
3  rS 
t  e 
en  La- 
96 
>384 
nd 
1536 
6144 
384 
1536 
3N§ 
192 
384 
nd 
192 
192 
Remarks 
days  days 
50  +18  Parotitis  followed  in  2 
days  by  encephalitis 
9  None  Parotitis  followed  in  2 
days  by  encephalitis 
--  +?  Minimal bilateral parotid 
swelling  coincident  to 
encephalitis 
8  None  Submaxillary swelling and 
orchitls 
16  None  Submaxillary  swelling  4 
days  after  onset  en- 
phalltis 
8  +21  Parotitls  4  days  before 
encephalitis 
17  Submaxillary  swelling  3 
32  +?  days before encephalitis 
17  None  Slight  swelling  left  paro- 
i  rid.  Testicular  pain 
time  of  encephalitis 
11  +42  Questionable swelling left 
parotid.  Orchitis time 
of  encephalitis.  Spinal 
fluid:  complement fixa- 
tion,  trace. 
--  +?  Parotitis 4 days before en- 
cephalitis.  Orchitis 
11  None  Parotitis  5  days  before 
encephalitis 
l 
17  None 
13  7  M  384  50  None 
Slight submaxillary swell- 
Lug  5  days  after  en- 
cephalitis 
Orchitls 3 days before en- 
cephalitis.  Spinal  fluid 
complement  fixation, 
negative 
* Titers given as reciprocals of final dilution of serum before addition of red blood cells. 
~: In the column  +  denotes history of exposure,  the figures,  days before onset of first 
symptoms of  disease.  In  those instances marked  "?,"  the  exact  time of exposure  could 
not be determined. 
§ Titer of third specimen taken 32 days after onset of encephalitis. LEWIS  W.  KAN]~  AND  JOHN  F. ENDERS  143 
TABLE I--Conduded 
14 
15 
16  M 
17 
Age  Sex 
year5 
2~  M 
13  M 
11 
6 
Case 
No. 
M 
I 
Comple-  1st serum  Comple-  2nd serum 
ment-  taken  [  ment-  taken 
fixing  (time after  fixing  (time after 
titer 1st  onset en-  [  titer 2rid  onset en- 
serum*  cephalitis  serum  I cephalitis) 
days 
192  13  nd 
96  7  1536  19 
384  10  384  29 
3  384  13 
Known 
exDos- 
ure 
(time 
before 
onset) 
days 
None 
Remarks 
Questionable  swelling  of 
submaxillary  gland 
same time as encepha- 
litis 
None[  Minimal bilateral parotid 
and submaxillary swell- 
ing same time as enceph- 
]  alitis 
None  Questionable swelling sub- 
lingual  glands  3  days 
after encephalitis 
None  ParotitiScephalitis2  days after en- 
obtained showed any increase in titer and in no case was a  significant titer of 
1:192  or  greater  recorded.  It would  seem highly  probable,  then,  that  the 
virus of mumps was  not  responsible for the  meningoencephalitis  of most of 
these cases, although on strictly clinical grounds, as will be subsequently shown, 
they could not be certainly distinguished from those included in group 2.  But 
because we have observed a patient with encephalitis following frank parotitis 
in whom antibody could not be demonstrated until about 6 weeks had elapsed 
(case 1, Table I), it is possible that a  very few of these patients in whom the 
results of the test remained unchanged during the period of observation never- 
theless developed antibody afterwards.  In our experience, however, both with 
undoubted mumps  meningoencephalitis and uncomplicated parotitis the case 
just  mentioned  is  the  only  individual  adequately  studied  by  means  of  the 
complement fixation test who failed  to develop antibody within a  period  of 
about  3  weeks  following  the  first  manifestation  of symptoms.  Accordingly 
such delayed expression of the antibody response is apparently a rare phenome- 
non. 
In respect to group 3 it is also of interest to note that from the spinal fluid 
of case 40 the virus of lymphochoriomeningitis was isolated.  This is additional 
evidence for the specific nature of the antibody response in mumps infection.* 
It is also to be observed that the test proved negative in 3  cases which were 
diagnosed on clinical grounds as poliomyelitis and in a 4th suspected of being 
poliomyelitis.  It would seem, therefore, that the test might be of assistance 
in the differential diagnosis of so called abortive poliomyelitis as well as other 
types of aseptic meningoencephalitis. 
8 See reference 1 for a discussion of the specificity  of the complement fixation test in mumps. TABLE  II 
Group g--Cases of Meningoencephalitis without Involvement of the Salivary  Glands Showing 
Significant  Titers  of Complement-Fixing Antibody 
Comple-  1st serum  Comple-  2nd serum  Known 
merit-  taken  ment-  taken  expos-  ure  Case  Age  Sex  fixing  (time after  fixing  (time after  (time 
No.  titer 1st  onset en-  titer 2nd  onset en- 
serum*  cephalitis)  serum  cephalitis) before  onset) 
years  days  days  days 
18  11  M  192  7  384  8  None 
19  2  M  0  5  192  14  3-21 
20  11  M  384  3  768  8  +? 
21  6  F  48  7  384  18  +21 
22  2~  F  384  21  nd§  -4-20 
23  5  M  192  20  nd  --  3-21 
24  22  M  384  14  nd  --  None 
25  3  M  192  7  nd  --  None 
26  61~  M  0  3  >92  8  3-? 
27  3~  M  96  10  384  18  3- 
28  5  M  96  7  384  15  None 
29  6~  M  384  4  384  25  +19 
30  1~  M  192  23  nd  --  3-? 
31  4~½  F  384  15  384  19  -4-14 
32  4  M  1536  16  nd  --  None 
33  11  M  >96  3  384  8  None 
Clinical diagnosis and remark~ 
Meningoencephalitis 
Lymphocytic  choriomer 
ingitis.  Mother,  sistel 
brother  had  mumps 
wks. before. Spinal flui, 
negative  for  antige: 
and antibody 
Encephalitis.  Spinal  flui, 
negative for antigen am 
antibody 
Mumps  encephalitis 
Brother had mumps 2 
days before 
Symptoms  compatibl 
with  mild  meningo 
encephalitis.  Sister  o 
No.  23 
Symptoms  compatibl, 
with  mild  meningoen 
cephalitis.  Brother  o 
No.  22 
Orchitis. Headache 2 wks. 
duration 
Encephalitis 
Mumps encephalitis? 
Meningitis? 
Encephalitis.  Spinal fluid 
complement  fixation 
negative 
Mumps  meningoencepha 
litis. Brother of No.  3( 
Mumps  meningoencepha 
litis. Mother had mump: 
9  days  before 
Meningoencephalitis? 
Brother  had  mumps 
same time 
Streptococcic  throat. 
Symptoms  of  nausea 
headache,  vomiting 
present.  Mother  ha¢ 
mumps  at  same  tim~ 
Mumps  encephalitis  fol 
lowed  by  orchitis 
* Titers given as reciprocals of final dilution of serum before addition of red blood cells. 
In the column +  denotes history of exposure, the figures, days before onset of first symp- 
toms of disease.  In those instances marked "?," the exact time of exposure could not be 
determined. 
§nd,  not  done. 
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A  cursory inspection of the summaries of clinical and epidemiologic observa- 
tions as well as the results of the routine laboratory procedures makes it appar- 
TABLE III 
Group 3--Cases of Meningoencephalitis without Involvement o/the Salivary Glands Wldch Did 
Not Show Significant  Titers of Complement-Fixing Antibody 
Case 
No,  ti 
S~ 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
~ple 
'.nt= 
ing 
r  lsl 
kli~* 
Clinical diagnosis and remarks 
Lymphocytic  choriomen- 
ingitis? 
Mumps encephalitis? 
Meningitis? 
Mumps  meningoencepha- 
litis? 
Meningopneumonitis 
Lymphocytic  choriomen- 
ingitis 
Mumps  meningoencepha- 
lit.is. Virus lymphocytic 
choriomeningitis  iso- 
lated  from spinal  fluid 
Poliomyelitis 
Encephalitis 
Poliomyelitis 
Poliomyelitis? 
Lymphocytic  choriomen- 
ingitis 
Poliomyelitis 
Mumps meningitis? 
Meningoencephalitis? 
Fever of unknown  origin. 
Headache,  stiff neck 
Meningoeneephalitis? 
Meningitis? 
* Titers  given as reciprocals of final dilution  of serum before addition of red blood cells. 
:~ Patient in Army Hospital--age not given on history. 
§ Titer of 3rd specimen taken  66 days after onset of encephalitis. 
ent that, save for the presence of a variable degree of enlargement of the salivary 
glands  or orchitis,  no single feature  distinguishes  any of the  51  cases which 
might be regarded as more than of suggestive value in the etiologic diagnosis. 
Thus  in accordance  with  the observations  of previous students  of mumps 
meningoencephalitis  without  salivary  gland  involvement,  our  findings  show 146  IMMUNITY  IN  M'U'M'PS.  ILl 
that  the  only presumptive diagnostic evidence of much importance consists 
in a reliable history of previous exposure to a case of mumps or the development 
of that disease more or less  contemporaneously in other members of the pa- 
tient's  family or  his  associates.  Though  of aid,  however,  when  it  can  be 
established, it is obvious from the records concerning exposure in Tables I and 
II that this criterion can be of no value in a large number of cases.  Thus only 
6 of the 17 patients who exhibited signs of infection of the salivary glands or 
testes associated with their encephalitis were able to state that they had been 
recently exposed to a case of mumps (Table I).  Likewise no history of exposure 
could be given by 6 of the 15 patients included in group 2 in 5 of whom the 
only manifestation of infection other than that afforded by the results of the 
complement fixation test was meningoencephalitis.  All the menbers of group 
3 who experienced a disease not definitely to be distinguished on clinical grounds 
from that afflicting the individuals in group 2  denied exposure.  It follows, 
therefore, that if one were to depend on the criterion of exposure alone, the 
etiologic diagnosis of nearly one-half the patients in group 2 would have re- 
mained entirely undefined.  It would also have been impossible with assurance 
to exclude as mumps meningoencephalitis the 17 cases in group 3. 
Of much less diagnostic aid are the other aspects of the disease.  Age does 
not serve to differentiate clearly these 3  groups.  As  one would expect the 
individuals  of groups  1 and  2  were made up  largely of children and young 
adults,  the  youngest  of  whom  was  1  {~  years  and  the  oldest  36  years. 
Group 3, with the exception of 2 persons of over 50 years of age, exhibited a 
similar range. 
In the 3 groups the distribution of meningoencephalitis according to sex was 
the same.  In each somewhat over twice as many males as females were encoun- 
tered.  This proportion is similar to that recorded by Holz and Tabor and 
Newman in their series of cases (7, 8).  In this connection, it is of interest to 
point out that the preponderance of males among the cases presumably due 
to  the virus of mumps does not follow the distribution according to sex of 
epidemic parotitis in which the attack rate of both sexes is the same (9). 
The signs and symptoms observed in each group were on the whole remark- 
ably uniform as  indicated by the summaries presented in Table IV.  It is, 
however, possible that the relatively low incidence of abdominal pain and the 
high  incidence of Kernig's  sign  in  group  3  may be  of  significance.  More 
definitely characteristic of this group would seem to be in most instances an 
insidious beginning of the disease as contrasted with the greater incidence of 
sudden onset recorded for group 2.  The duration of illness as compared with 
both the other groups also distinguished group 3.  If, then, the symptoms of 
meningoencephalitis develop slowly and persist longer than about 1 week, it 
suggests that the etiologic agent may be other than the virus of mumps.  But 
there have been sufficient exceptions in all the groups to render such evidence 
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The behavior of the  white blood  cells both  in  the  blood  and  spinal fluid 
likewise affords no reliable index to the responsible agent.  It will be remarked 
(Table V) that the mean total counts of blood and spinal fluid from the cases 
in groups  1 and 2  as well as the percentage distribution  of lymphocytes are 
almost identical.  In group 3  the total white blood count on the average is 
slightly higher and that of the spinal fluid definitely lower than in the first 2 
groups.  In the case of the blood the difference appears to be due to the inclu- 
sion of 4 individuals in group 3 exhibiting counts significantly higher than any 
of those encountered in the other groups (i.e. cases 36, 39, 50, 51).  The lower 
mean value of the total count of the spinal fluid is obviously influenced greatly 
by the extremely low figure for case 44,  although  the counts in general tend 
to be somewhat less than those for groups 1 and 2.  The percentage of lympho- 
cytes in the blood is also slightly less in group 3 but again this would appear 
TABLE IV 
Clinical  Data--Cases  of  Menlngoencephalitis 
Percentage  of group exhibiting 
No.  Dura- 
Group  in  tion  Abdom-Nau-  Vomit-  Head-  Leth-  Convul-Nuchal  Babin-  Kernig 
groul  averag,  ,nsel~Cut  paininal  sea  ing  ache  argy  sions  rigidity  ski 
days 
1  17  7.6  *  24  24  59  82  12  12  82  6  19 
2  16  7.4  68  31  19  69  63  38  13  81  6  31 
3  18  10.7  28  11  28  61  78  22  6  78  6  50 
• Time of onset in this group could not be determined accurately since symptoms due to 
orchitis or salivary gland involvement obscured the onset of meningoencephalifis. 
to be attributable to the inclusion of a  small number of cases with unusually 
low values  (cases 34,  36,  45,  51).  Moreover a  very slight depression in  the 
mean percentage  of lymphocytes can be assigned  largely to  the  differential 
findings of 2  cases  (36 and 51)  Since these 2 cases appear  to  be  unlike  the 
others in respect both to high total white blood count and low percentage of 
lymphocytes in blood or spinal fluid, it would be perhaps justifiable to conclude 
on the basis of these criteria alone that the mumps virus was not concerned. 
Such a  conclusion, at least in case 51,  is further supported by the findings of 
Silwer (10)  who observed no case of what he believed to be mumps meningo- 
encephalitis in which the lymphocytes of the spinal fluid represented less than 
45 per cent of the cells.  In respect to the leucocytes of the blood and spinal 
fluid, it may then be stated that with these 2 possible exceptions the cou,nts, 
total and differential, do not serve to distinguish  the cases of group 3. 
The raflges of the protein concentration of the spinal fluid in groups 1 and 2 
were almost identical although  indicating an increase above the normal  (see 
page 139).  For group 3 the range was somewhat more extensive and in certain 148  IMMUNITY IN MUMPS.  HI 
individuals  concentrations  were  recorded  which  were  definitely  greater  than 
in the other 2  groups.  The data therefore suggest that if the concentration is 
higher than about  75 rag. per ml. the causative agent may not be the virus of 
mumps.  Again,  however,  there  were  a  number  of  instances  in  group  3  in 
TABLE V 
Leucocyte  Counts-Blood and Sfinal Fluid--Cases of Meningoencephalitis 
Group I  Group 2  Group 3 
thou-  tm"  per  thou-  thou-  sands/  sands/  per  per  sands/  per  per 
cen~  cen~  gent  gent  ¢en~  ¢en~  c.mm.  C.mm.  c.mm. 
1  5.9  15  280  100  18  8.1  47  750  100  34  5.2  10  135  85 
2  8.9  26  8  I00  19  10.6  53  180  88  35  4.3  23  24  100 
3  7.2  70  1350  96  20  7.2  54  807  99  36  28.5  11  376  35 
4  4.4  38  --  --  21  12.0  36  100  85  37  10.6  24  36  100 
5  --  --  22  .  --.38  4.8  22  80  94 
6  10.6  25  7  I00  23  .... 39  16.0  25  64  90 
7  6.0  ~0  220  100  24  8.5  --  241  99  40  6.6  28  1110  90 
8  ~  --  25  6.0  [~3  106  90  41  7.5  73  17  100 
9  ~  i24  1200  ~96  26  3.3  119  210  99  42  8.0  56  670  96 
10  8.8  ]54  178  ]100  27  8.2  !37  76  100  43  14.0  16  142  98 
11  23  100  28  13.0  22  1110  95  44  8.2  20  2  100 
12  12.5  35  --  29  7.4  19  33  --  45  11.9  12  95  87 
13  6.1  [35  1200  94  30  8.2  ]34  605  --  46  8.3  30  37  100 
14  5.6  92  --  31  11.5  58  792  95  47  10.5  19  76  95 
15  6.5  55  204  100  32  ....  48  11.1  24  45  100 
16  --  33  9.0  30  270  70  49  9.4  28  26  100 
17  9.0  6  110  80  50  16.9  19  948  100 
51  17.4  7  1200  15 
~.ver-  282.4  age..  7.6  39.6  434.5  96.8  8.7  37.7  405.4  92.7  9.9  24.3  88.1 
which  the  concentration  was  comparable  to  that  characteristic  of  mumps 
meningoencephafitis. 
In respect to the seasonal distribution of our cases, it is apparent from Table 
VI that during the first 7 months of the year 94 per cent of the cases in group 1 
and  73 per cent of those in group 2 occurred.  In contrast only 35 per cent of 
the cases in group 3 became ill during the same period.  Although the numbers 
are too few to furnish an adequate basis for statistical evaluation, this distribu- 
tion  is of  some interest,  since for groups  1  and  2  it follows to a  considerable LEWIS W. KAzN~ AND JOI~II~  :F. ENDERS  149 
degree the seasonal distribution curve of mumps in the United States (9) and 
so can perhaps he regarded as supportive evidence for the nature of the etiologic 
agent in those groups.  Conversely since the distribution of the cases in group 3 
is quite different, further indication of a diverse origin of certain of them would 
appear to be presented.  It is  equally  apparent,  however,  that  it  would  be 
entirely misleading to assert that because a case of meningoencephalitis occur- 
red during the late summer or early fall, it was very unlikely that  the virus 
of mumps was responsible---the chances of its being so would merely seem to 
be somewhat less than during the earlier part of the year as suggested by the 
data here recorded as well as by the fact that the incidence of uncomplicated 
mumps is low during that time. 
TABLE VI 
Seasonal  Distribution  of  Cases of  Meningoenceptuffilis 
Month 
Jan  ......................................... 
Feb  ......................................... 
Mar  ......................................... 
Apr  ......................................... 
May  ........................................ 
June  ........................................ 
July ........................................ 
Aug  ......................................... 
Sept  ........................................ 
Oct  ......................................... 
NOV ......................................... 
Dec ......................................... 
Group 1 
1 
1 
5 
5 
2 
1 
1 
1 
No.  of cases 
Group 2 
2 
1 
1 
2 
2 
3 
2 
2 
Group 3 
d 
2 
1 
1 
3 
2 
4 
3 
2 
SUMMARY 
1.  Fifty-one patients  exhibiting  signs  and  symptoms compatible with  the 
clinical syndrome of acute aseptic meningoencephalitis have been studied  by 
means  of  the  complement fixation  test  for  the  demonstration  of  antibody 
reacting with the virus of mumps or its products. 
2.  In 17 of these individuals in whom the clinical diagnosis could be made 
with assurance because of an associated enlargement of the salivary glands, 
the test yielded evidence of recent infection with the virus. 
3.  In  16  patients  without  involvement of the  salivary glands  the  results 
of the test likewise indicated  recent infection with this virus. 
4.  In the remaining 18 patients the test gave no evidence of a  recent infec- 
tion with the virus. 
5.  Except for histories of recent exposure obtained  from certain of the in- 150  IMMUNITY IN MD'M~S.  III 
dividuals in whom the complement fixation test was considered to be positive, 
the characteristics of  the disease and  the data afforded by the usual  labora- 
tory studies failed to distinguish the last 2 groups. 
6.  On the basis of these findings, it is concluded that the complement fixation 
test should be of value in the diagnosis of those cases of acute aseptic meningo- 
encephalitis in which the virus of mumps is the etiologic agent and in which 
involvement of the salivary glands is slight or absent. 
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